MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with C

Carbamazepine

Carbamazepine 100mg tablets

Incompatible

Stability notes for Carbamazepine 100mg tablets

Very moisture sensitive medicine.
Manufacturer recommends storing in original container. May lose a third or more oral bioavailability when exposed to excessive moisture. Protect from light

Provenance

This recommendation is based on the products Tegretol 100mg tablets (Novartis Pharmaceuticals UK Ltd) and Carbamazepine Crescent 100 mg tablets (Crescent Pharma Limited).

Suppliers (8) of Carbamazepine 100mg tablets
Carbamazepine 100mg tablets (A A H Pharmaceuticals Ltd)
Carbamazepine 100mg tablets (Alliance Healthcare (Distribution) Ltd)
Carbamazepine 100mg tablets (Crescent Pharma Ltd)
Carbamazepine 100mg tablets (Medihealth (Northern) Ltd)
Carbamazepine 100mg tablets (Medreich Plc)
Carbamazepine 100mg tablets (Noumed Life Sciences Ltd)
Carbamazepine 100mg tablets (Umedica Laboratories UK Ltd)
Tegretol 100mg tablets (Novartis Pharmaceuticals UK Ltd)

Carbamazepine 200mg modified-release tablets

Incompatible

Stability notes for Carbamazepine 200mg modified-release tablets

Very moisture sensitive medicine.
Manufacturer recommends storing in original container. May lose a third or more oral bioavailability when exposed to excessive moisture. Protect from light

Provenance

This compatibility recommendation is based on the products Tegretol Prolonged Release 200mg tablets (Novartis Pharmaceuticals UK Ltd).

Suppliers (6) of Carbamazepine 200mg modified-release tablets
Carbamazepine 200mg modified-release tablets (A A H Pharmaceuticals Ltd)
Carbamazepine 200mg modified-release tablets (Drugsrus Ltd)
Curatil Prolonged Release 200mg tablets (Tillomed Laboratories Ltd)
Tegretol Prolonged Release 200mg tablets (Necessity Supplies Ltd)
Tegretol Prolonged Release 200mg tablets (Novartis Pharmaceuticals UK Ltd)
Tegretol Prolonged Release 200mg tablets (Sigma Pharmaceuticals Plc)

Carbamazepine 200mg tablets

Incompatible

Stability notes for Carbamazepine 200mg tablets

Very moisture sensitive medicine.
Manufacturer recommends storing in original container. May lose a third or more oral bioavailability when exposed to excessive moisture. Protect from light

Provenance

This recommendation is based on the products Tegretol 200mg tablets (Novartis Pharmaceuticals UK Ltd) and Carbamazepine Crescent 200 mg tablets (Crescent Pharma Limited).

Suppliers (8) of Carbamazepine 200mg tablets
Carbamazepine 200mg tablets (A A H Pharmaceuticals Ltd)
Carbamazepine 200mg tablets (Alliance Healthcare (Distribution) Ltd)
Carbamazepine 200mg tablets (Crescent Pharma Ltd)
Carbamazepine 200mg tablets (Medihealth (Northern) Ltd)
Carbamazepine 200mg tablets (Medreich Plc)
Carbamazepine 200mg tablets (Noumed Life Sciences Ltd)
Carbamazepine 200mg tablets (Umedica Laboratories UK Ltd)
Tegretol 200mg tablets (Novartis Pharmaceuticals UK Ltd)

Carbamazepine 400mg modified-release tablets

Incompatible

Stability notes for Carbamazepine 400mg modified-release tablets

Very moisture sensitive medicine.
Manufacturer recommends storing in original container. May lose a third or more oral bioavailability when exposed to excessive moisture. Protect from light

Provenance

This recommendation is based on the products Tegretol Prolonged Release 400mg tablets (Novartis Pharmaceuticals UK Ltd).

Suppliers (7) of Carbamazepine 400mg modified-release tablets
Carbamazepine 400mg modified-release tablets (A A H Pharmaceuticals Ltd)
Carbamazepine 400mg modified-release tablets (Drugsrus Ltd)
Tegretol Prolonged Release 400mg tablets (Lexon (UK) Ltd)
Tegretol Prolonged Release 400mg tablets (Necessity Supplies Ltd)
Tegretol Prolonged Release 400mg tablets (Novartis Pharmaceuticals UK Ltd)
Tegretol Prolonged Release 400mg tablets (Pilsco Ltd)
Tegretol Prolonged Release 400mg tablets (Sigma Pharmaceuticals Plc)

Carbamazepine 400mg tablets

Incompatible

Stability notes for Carbamazepine 400mg tablets

Very moisture sensitive medicine.
Manufacturer recommends storing in original container. May lose a third or more oral bioavailability when exposed to excessive moisture. Protect from light

Provenance

This recommendation is based on the products Tegretol 400mg tablets (Novartis Pharmaceuticals UK Ltd) and Carbamazepine Crescent 400 mg tablets (Crescent Pharma Limited).

Suppliers (8) of Carbamazepine 400mg tablets
Carbamazepine 400mg tablets (A A H Pharmaceuticals Ltd)
Carbamazepine 400mg tablets (Alliance Healthcare (Distribution) Ltd)
Carbamazepine 400mg tablets (Crescent Pharma Ltd)
Carbamazepine 400mg tablets (Medihealth (Northern) Ltd)
Carbamazepine 400mg tablets (Medreich Plc)
Carbamazepine 400mg tablets (Noumed Life Sciences Ltd)
Carbamazepine 400mg tablets (Umedica Laboratories UK Ltd)
Tegretol 400mg tablets (Novartis Pharmaceuticals UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.